TA
NKTR icon

Teachers Advisors’s Nektar Therapeutics NKTR Stock Holding History

Teachers Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$18.4M Buy
36,460
+6,454
+22% +$3.82M 0.02% 701
2018
Q4 		$14.8M Buy
30,006
+1,019
+4% +$615K 0.02% 731
2018
Q3 		$26.5M Sell
28,987
-1,289
-4% -$1.1M 0.03% 574
2018
Q2 		$22.2M Sell
30,276
-25,528
-46% -$29.4M 0.03% 674
2018
Q1 		$88.9M Sell
55,804
-6,224
-10% -$8.02M 0.12% 200
2017
Q4 		$55.6M Buy
62,028
+17,072
+38% +$10.1M 0.07% 320
2017
Q3 		$16.2M Sell
44,956
-816
-2% -$255K 0.02% 796
2017
Q2 		$13.4M Buy
45,772
+1,550
+4% +$448K 0.02% 857
2017
Q1 		$15.6M Buy
44,222
+22,525
+104% +$5.06M 0.02% 774
2016
Q4 		$3.99M Buy
21,697
+3,166
+17% +$644K 0.01% 1394
2016
Q3 		$4.78M Sell
18,531
-1,643
-8% -$423K 0.01% 1226
2016
Q2 		$4.31M Buy
20,174
+837
+4% +$187K 0.01% 1234
2016
Q1 		$3.99M Buy
19,337
+28
+0.1% +$5.38K 0.01% 1228
2015
Q4 		$4.88M Buy
19,309
+160
+0.8% +$32.9K 0.01% 1152
2015
Q3 		$3.15M Buy
19,149
+37
+0.2% +$6.54K 0.01% 1320
2015
Q2 		$3.59M Buy
19,112
+562
+3% +$96.7K 0.01% 1317
2015
Q1 		$3.06M Buy
18,550
+541
+3% +$111K 0.01% 1396
2014
Q4 		$4.19M Buy
18,009
+21
+0.1% +$4.49K 0.01% 1206
2014
Q3 		$3.26M Buy
17,988
+887
+5% +$170K 0.01% 1306
2014
Q2 		$3.29M Buy
17,101
+335
+2% +$59.2K 0.01% 1316
2014
Q1 		$3.05M Buy
16,766
+1,186
+8% +$235K 0.01% 1334
2013
Q4 		$2.65M Buy
15,580
+538
+4% +$86.8K 0.01% 1379
2013
Q3 		$2.36M Buy
15,042
+1,101
+8% +$204K 0.01% 1373
2013
Q2 		$2.42M Buy
+13,941
New +$2.14M 0.01% 1320

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Teachers Advisors's NKTR Position: Q1 2019 in Review

Teachers Advisors increased its Nektar Therapeutics (NKTR) stake by 22% in Q1 2019, buying an estimated $3.82M and bringing the position to 36,460 shares worth $18.4M. The position accounts for 0.02% of the portfolio, ranked #701.

Teachers Advisors first reported a position in NKTR in Q2 2013 and has held it in 24 quarters since. The position peaked at $88.9M in Q1 2018. 349 funds tracked by Wall St. Rank hold NKTR as of Q1 2019.

  • Teachers Advisors held 36,460 shares of Nektar Therapeutics worth $18.4M as of Q1 2019.
  • Teachers Advisors bought 6,454 Nektar Therapeutics shares in Q1 2019, an estimated $3.82M.
  • Nektar Therapeutics made up 0.02% of Teachers Advisors's portfolio in Q1 2019, its #701 holding.
  • Teachers Advisors first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Nektar Therapeutics position peaked at $88.9M in Q1 2018.
  • 349 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.